Sabby Management’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-8
Closed -$222K – 335
2015
Q1
$222K Buy
+8
New +$1.65K 0.01% 263

Other funds holding CTSO

Sabby Management's CTSO Position: Q3 2017 in Review

Sabby Management sold out of Cytosorbents (CTSO) in Q3 2017, closing a stake of 8,605 shares — an estimated $740K sold.

Sabby Management first reported a position in CTSO in Q1 2017 and held it in 2 quarters. The position peaked at $990K in Q1 2017. 31 funds tracked by Wall St. Rank hold CTSO as of Q3 2017.

  • Sabby Management reported no remaining Cytosorbents position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 8,605 Cytosorbents shares in Q3 2017, an estimated $740K.
  • Sabby Management first reported a position in Cytosorbents in Q1 2017 and held it in 2 quarters.
  • Sabby Management's Cytosorbents position peaked at $990K in Q1 2017.
  • 31 funds tracked by Wall St. Rank held Cytosorbents as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.